Vinorelbine (Sagent Pharmaceuticals)


Welcome to the PulseAid listing for the Vinorelbine drug offered from Sagent Pharmaceuticals. This Vinca Alkaloid [EPC],Vinca Alkaloids [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Sagent Pharmaceuticals
NON-PROPRIETARY NAME: Vinorelbine
SUBSTANCE NAME: VINORELBINE TARTRATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Vinca Alkaloid [EPC],Vinca Alkaloids [Chemical/Ingredient]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2014-09-15
END MARKETING DATE: 0000-00-00


Vinorelbine HUMAN PRESCRIPTION DRUG Details:

Item DescriptionVinorelbine from Sagent Pharmaceuticals
LABELER NAME: Sagent Pharmaceuticals
DEA SCHEDULE:
ACTIVE STRENGTH: 10(mg/mL)
START MARKETING DATE: 2014-09-15
END MARKETING DATE: 0000-00-00
PRODUCT ID: 25021-204_753fafca-59aa-454d-979e-9f7feec3bc7a
PRODUCT NDC: 25021-204
APPLICATION NUMBER: ANDA091106

Other VINORELBINE TARTRATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Hospira, Inc.VINORELBINE
Pierre Fabre Pharmaceuticals, Inc.NAVELBINE
Sagent PharmaceuticalsVinorelbine
Teva Parenteral Medicines, Inc.Vinorelbine
Wyeth Pharmaceuticals Companyvinorelbine tartrate